Search Results 71-80 of 16975 for IBS
Irritable bowel syndrome (IBS). National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/digestive ...
... (IBS) based on the Rome III criteria and to determine fecal microbiota changes in concordant and discordant twins with IBS. Participation eligibility.
This digestive condition happens when part of the small intestine is missing or damaged, either at birth or after surgery. The syndrome keeps you from ...
About this study. The primary objectives of this study are to explore the therapeutic effect of eluxadoline in treating IBS-D in pediatric patients 12-17 ...
Mayo Clinic's Gastrointestinal Barrier Function Lab, led by Madhu Grover, M.B.B.S., advances the understanding of irritable bowel syndrome (IBS), ...
Will Ranolazine improve bowel function and abdominal pain in human subjects with IBS-D? Participation eligibility. Participant eligibility includes age ...
Study to Better Understand the Development of Irritable Bowel Disease (IBD) and Related Diseases as a Step Toward Improving Disease Outcomes. · Share · Facebook ...
These symptoms can be consistent with post-infectious irritable bowel syndrome (IBS) and can last long after the acute infection is over. ... Post Infectious IBS ...
The purpose of this study is to evaluate gastric, small-bowel, and colonic transit in subjects with IBS-C and IBS-D treated with multiple (three times daily) ...
... Irritable Bowel Syndrome (IBS-D). Print details. Share; Facebook · Twitter ... IBS-D. Participation eligibility. Participant eligibility includes age, gender ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.